Li Ye

405 total citations
36 papers, 237 citations indexed

About

Li Ye is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Li Ye has authored 36 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hematology, 11 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Li Ye's work include Acute Myeloid Leukemia Research (26 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers) and Multiple Myeloma Research and Treatments (5 papers). Li Ye is often cited by papers focused on Acute Myeloid Leukemia Research (26 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers) and Multiple Myeloma Research and Treatments (5 papers). Li Ye collaborates with scholars based in China, United States and United Kingdom. Li Ye's co-authors include Hongyan Tong, Jie Jin, Mengxia Yu, Xinping Zhou, Chao Hu, Chen Mei, Liya Ma, Zhengping Zhuang, Weilai Xu and Yanling Ren and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Medicine.

In The Last Decade

Li Ye

32 papers receiving 236 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Ye China 8 195 76 73 43 40 36 237
Diego Quinones Raffo United States 9 152 0.8× 83 1.1× 72 1.0× 41 1.0× 44 1.1× 17 304
Luxi Song China 11 233 1.2× 120 1.6× 88 1.2× 42 1.0× 68 1.7× 32 347
Liwei Fang China 11 244 1.3× 108 1.4× 147 2.0× 18 0.4× 28 0.7× 31 329
J. Maciejewski United States 7 259 1.3× 180 2.4× 107 1.5× 40 0.9× 30 0.8× 10 345
Jayashree Motwani United Kingdom 9 238 1.2× 72 0.9× 71 1.0× 17 0.4× 42 1.1× 24 324
Amir T. Fathi United States 7 175 0.9× 73 1.0× 95 1.3× 13 0.3× 32 0.8× 24 233
Ryan J. Stubbins Canada 9 102 0.5× 94 1.2× 81 1.1× 21 0.5× 80 2.0× 26 286
H. Kreipe Germany 5 124 0.6× 42 0.6× 48 0.7× 26 0.6× 28 0.7× 13 172
Mridul Agrawal United States 8 187 1.0× 64 0.8× 128 1.8× 56 1.3× 33 0.8× 12 289
Sophia Balderman United States 8 135 0.7× 78 1.0× 49 0.7× 17 0.4× 59 1.5× 19 234

Countries citing papers authored by Li Ye

Since Specialization
Citations

This map shows the geographic impact of Li Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Ye more than expected).

Fields of papers citing papers by Li Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Ye. The network helps show where Li Ye may publish in the future.

Co-authorship network of co-authors of Li Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Li Ye. A scholar is included among the top collaborators of Li Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Ye. Li Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Li, Jingjing Deng, Yuan Jian, Zhiyao Zhang, & Wenming Chen. (2025). Is t(11;14) in newly diagnosed multiple myeloma a favorable outcome in the novel agent era?. Blood Research. 60(1). 11–11.
2.
Zhang, Yalei, Ling Qian, Kai Chen, et al.. (2025). Cryoablation plus sintilimab and lenvatinib in advanced or metastatic intrahepatic cholangiocarcinoma: a phase 2 trial. Nature Cancer. 7(1). 60–79.
3.
4.
Lin, Wenyu, et al.. (2025). Risk of residual/recurrent cervical diseases in HPV-positive women post-conization depends on HPV integration status. Infectious Agents and Cancer. 20(1). 5–5. 1 indexed citations
5.
Luo, Yingwan, Xiaomin Feng, Wei Lang, et al.. (2024). Ectopic expression of the transcription factor ONECUT3 drives a complex karyotype in myelodysplastic syndromes. Journal of Clinical Investigation. 134(8). 1 indexed citations
6.
Liu, Yang, Li Ye, Lin Feng, et al.. (2022). The Importance of FISH Signal Cut-off Value and Copy Number Variation for 1q21 in Newly Diagnosed Multiple Myeloma: Is it Underestimated?. Clinical Lymphoma Myeloma & Leukemia. 22(7). 535–544. 14 indexed citations
7.
Ye, Li, Liya Ma, Yanling Ren, et al.. (2022). Predictive values of mutational variant allele frequency in overall survival and leukemic progression of myelodysplastic syndromes. Journal of Cancer Research and Clinical Oncology. 148(4). 845–856. 6 indexed citations
8.
9.
10.
Ren, Yanling, Wei Lang, Chen Mei, et al.. (2022). Co‐mutation landscape and clinical significance of RAS pathway related gene mutations in patients with myelodysplastic syndrome. Hematological Oncology. 41(1). 159–166. 7 indexed citations
11.
12.
13.
Luo, Yingwan, Lu Wang, Liya Ma, et al.. (2019). Mutation status and burden can improve prognostic prediction of patients with lower‐risk myelodysplastic syndromes. Cancer Science. 111(2). 580–591. 29 indexed citations
14.
Ye, Li, Yanling Ren, Xinping Zhou, et al.. (2019). Decitabine improves overall survival in myelodysplastic syndromes-RAEB patients aged ≥60 years and has lower toxicities: Comparison with low-dose chemotherapy. Blood Cells Molecules and Diseases. 77. 88–94. 4 indexed citations
15.
Lin, Peipei, Yingwan Luo, Dominic Maggio, et al.. (2018). Isocitrate dehydrogenase 2 mutations correlate with leukemic transformation and are predicted by 2-hydroxyglutarate in myelodysplastic syndromes. Journal of Cancer Research and Clinical Oncology. 144(6). 1037–1047. 17 indexed citations
16.
Ren, Yanling, Chen Mei, Li Ye, et al.. (2018). Analysis of clinical and molecular features of MDS patients with complex karyotype in China. Blood Cells Molecules and Diseases. 75. 13–19. 9 indexed citations
17.
Ye, Li, Mengmeng Ji, & Zimin Sun. (2015). [FLT3 Gene Mutations in Acute Myeloid Leukemia].. PubMed. 23(2). 322–7. 1 indexed citations
18.
Jin, Jie, Chao Hu, Mengxia Yu, et al.. (2014). Prognostic Value of Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes: A Retrospective Cohort Study and Meta-Analysis. PLoS ONE. 9(6). e100206–e100206. 47 indexed citations
19.
Lin, Bo-Wen, Hongfa Yang, Mengzhao Cui, Li Ye, & Jinlu Yu. (2014). Surgicel™ application in intracranial hemorrhage surgery contributed to giant-cell granuloma in a patient with hypertension: case report and review of the literature. World Journal of Surgical Oncology. 12(1). 101–101. 20 indexed citations
20.
Jin, Jie, Mengxia Yu, Chaosu Hu, et al.. (2014). Pesticide Exposure as a Risk Factor for Myelodysplastic Syndromes: A Meta-Analysis Based on 1,942 Cases and 5,359 Controls. PLoS ONE. 9(10). e110850–e110850. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diego Quinones Raffo Breakdown of academic impact, for papers by Luxi Song Breakdown of academic impact, for papers by Liwei Fang Breakdown of academic impact, for papers by J. Maciejewski Breakdown of academic impact, for papers by Jayashree Motwani Breakdown of academic impact, for papers by Amir T. Fathi Breakdown of academic impact, for papers by Ryan J. Stubbins Breakdown of academic impact, for papers by H. Kreipe Breakdown of academic impact, for papers by Mridul Agrawal Breakdown of academic impact, for papers by Sophia Balderman
Rankless by CCL
2026